FDA Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft

标准简介

Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft[附网盘链接]是于不久之前发布的FDA标准,适用于美国。

标准截图

Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft[附网盘链接]
Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft[附网盘链接](截图)

 

标准文档说明

标准文档类型为Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft[附网盘链接]高清PDF版本(文字版),标准文档内可进行搜索,可以复制原文,可粘贴。

标准部分原文

Draft – Not for Implementation

47 Denture Base Resins – Performance 48 Criteria for Safety and Performance 49 Based Pathway

50 ______________________________________________________________________________

51 Draft Guidance for Industry and

52 Food and Drug Administration Staff

53

54 This draft guidance, when finalized, will represent the current thinking of the Food and Drug 55 Administration (FDA or we) on this topic. It does not establish any rights for any person and 56 is not binding on FDA or the public. You can use an alternative approach if it satisfies the 57 requirements of the applicable statutes and regulations. To discuss an alternative approach, 58 contact the FDA staff or Office responsible for this guidance as listed on the title page.

59 I. Introduction

60 This draft guidance provides performance criteria for denture base resins in support of the Safety 1

61 and Performance Based Pathway. Under this framework, submitters (you) planning to submit a 62 510(k) using the Safety and Performance Based Pathway for denture base resins will have the 63 option to use the performance criteria proposed in this draft guidance to support substantial 64 equivalence, rather than a direct comparison of the performance of the subject device to that of a 65 predicate device.

66

67 For the current edition of the FDA-recognized consensus standard(s) referenced in this 2

68 document, see the FDA Recognized Consensus Standards Database. For more information 69 regarding use of consensus standards in regulatory submissions, please refer to the FDA 70 guidance titled Appropriate Use of Voluntary Consensus Standards in Premarket Submissions 3

71 for Medical Devices. 72

73 The contents of this document do not have the force and effect of law and are not meant to bind 74 the public in any way, unless specifically incorporated into a contract. This document is intended 75 only to provide clarity to the public regarding existing requirements under the law. FDA 76 guidance documents, including this guidance, should be viewed only as recommendations, unless 1

Available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/safety-and-performance-

based-pathway 2

Available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm 3

Available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/appropriate-use-

voluntary-consensus-standards-premarket-submissions-medical-devices

网盘链接

百度网盘:https://pan.baidu.com/s/1abs6fjqidNYB8jamwZ31cw
提取码:2a1q

【温馨提示】大资料ISO是提供信息发布的专业信息类网站,所有内容均由用户发布,不代表本站观点,本站亦不存储所涉及的文件及资料。如有【免费资料】以及【付费资料】,请用户根据自己的需求,自行判断是否需要获取。如有交易诈骗、内容侵权可发送邮件至kf@dzl100.com,我们审查后若发现情况属实,会立即对相关内容进行删除处理。

加载用时:41.2152 毫秒

相关评论

相关文章